Ascendis Pharma Growth Disorders A/s

This 3-year study is testing whether a combination of two weekly injection drugs can safely help children with achondroplasia grow faster. It involves 22 children aged 2 to 11 and will measure their yearly growth rate and monitor for side effects. The goal is to see if using both…

This study continues testing a weekly injection called TransCon CNP in children and teenagers with achondroplasia, a genetic condition that affects bone growth. It's for participants who have already completed an earlier trial with the same medication. The main goals are to check…